Primary immunodeficiency diseases (PIDD) are inherited disorders resulting from defects in diverse elements of the human immune system. Currently, more than 330 PIDDs have been described, and the molecular (genetic) bases for more than 320 of them are known. PIDD can be divided into nine different groups, including antibody (humoral) deficiencies, innate/intrinsic deficiencies, phagocytic system deficiencies, complement component deficiencies, combined (T and B cells) immunodeficiencies, syndromic combined immunodeficiencies, immune dysregulation disorders, autoinflammatory diseases and phenocopies of PIDD. In the PIDD group, primary antibody deficiencies are the most common group, and approximately 50% of patients with PIDD fall into this group of deficiencies. Congenital primary immunodeficiencies typically appear early in life, although late onset is gradually more identified. Affected patients usually present clinically with recurrent/ severe infections, or clinical pictures resembling various autoimmune or other diseases. An early diagnosis of congenital immunodeficiencies is necessary for transfer to specialized medical centers, and prompt commencement of the optimal treatment, including transplantation and enhanced outcomes. In this review, a general approach is described for the investigation of the most common groups of PIDD, outlining the most appropriate laboratory investigations when the clinician comes across typical clinical pictures and/or infections suggesting immunodeficiency.
INTRODUCTION
In this review, an anamnesis (history of infection and disease) and laboratory findings will be evaluated together with laboratory tests relevant to the primary immunodeficiency disease (PID) group.
In most cases, the investigations focus on a certain PID group according to the type of infection or disease encountered in the clinic. For example, in cases of viral and fungal infections, the efforts are directed to T cells, and in infections caused by encapsulated bacteria, B cells are implicated. In infections with certain microorganisms such as Neisseria meningitis, complement system dysfunction is implicated, whereas in Serratia and organ abscesses, an involvement of phagocytic cells, and in Herpes encephalitis, Toll-like receptor disorders, are suspected.
[1] Systemic lupus erythematosus (SLE) and hemolytic uremic syndrome are frequently seen diseases that suggest a dysfunction of the complement system; gingivit-stomatitis and abscesses imply phagocytic system disorders, and the sinopulmonary system diseases are suggestive of the humoral immune system (antibody deficiency) disorders. [1] [2] [3] [4] [5] [6] [7] [8] [9] Apart from the infections we have encountered in the clinic, different disease types, including autoimmune cytopenia, thrombocytopenia, hepatosplenomegaly, eczema, telangiectasia, partial albinism, inflammatory bowel syndrome, chronic diarrhea, chronic giardiasis, chronic mucocutaneous candidiasis, pulmonary abscesses, pneumatoceles, recurrent fever, and rheumatic complaints may lead to immune system disorders that can be categorized in seven important groups (combined [cellular+humoral and syndromic] and phenocopic immunodeficiencies, phagocytosis, complement system deficiencies, immune dysregulation and natural/structural immune system response disorders, and autoinflammatory syndromes). [10] After some basic screening tests are explained, we will talk about the tests that may be requested in the advanced stage. In this review, starting from antibody deficiencies (humoral immune system disorders), an approach to the five most known PID groups will be described.
1) Evaluation of antibody deficits
In our country, as well as in the world, antibody deficiencies are the most common PIDs we encounter. Selective IgA deficiency and transient hypogammaglobulinemia in infants are among the leading disorders in our country. [11] [12] [13] [14] [15] Initially, quantitative immunoglobulin isotype values for age, screening tests, specific antibody levels after natural immunity (spontaneous) and immunization (vaccination), and IgG subgroup (IgG1-G2-G3-G4) levels are examined. In vitro functional studies that can evaluate Bcell immunophenotyping and antibody production can be performed in advanced centers. Again, especially in the differential diagnosis, in order to rule out thymoma in patients >50 years of age with low B-cell counts, thorax CT, sweat test for cystic fibrosis, fecal α1-antitrypsin, the urine protein/serum albumin level, absolute lymphocyte count, as well as tests to exclude loses with feces and urine or through the lymphatic system may be required (Table 1) .
Immunoglobulin isotype values and their interpretation
There are no strict standards in the diagnosis of immunoglobulin (antibody) deficiency. According to the common assumption, the immunoglobulin value under two standard deviations for age is considered as deficiency, that is, hypogammaglobulinemia. Some experts say that age-appropriate reference (confidence) intervals (95% CI) should be evaluated. [3] [4] [5] [6] [7] [8] [9] Levels below the normal values for that particular age require examination. The normal values for age were determined in studies conducted in our country. [16, 17] Regardless of the age-appropriate values in adolescents and adults, an IgG value <300-400 mg/dL (3-4 g/L) and in infants <100 mg/dL is evaluated as hypogammaglobulinemia without doubt. [3, 6] However, agammaglobulinemia is defined as an IgG value <100 mg/dL. Again, in this case IgM <20 mg/ dL, IgA <10 mg/dL, and peripheral blood CD19 + -B-cell <2% signify agammaglobulinemia. [8, 18, 19] 
Values of IgG subgroups and their interpretations
The value of the immunoglobulin subgroup below two standard deviations with regard to age is considered to be deficiency. Some experts say that evaluations should be made according to an age-appropriate reference (confidence) intervals (95% CI). [6] In particular, the evaluation of IgG subgroups in selective IgA deficiency patients with recurrent bacterial infections is particularly useful. If treatment of IgG subgroup deficiencies is expected to be initiated, it is necessary to show a specific antibody deficiency first.
Spontaneous/natural (specific) antibody (isohemaglutinin) titers
Spontaneous specific antibody titer is the anti-IgG (isohemaglutinin) titer, which is formed against the blood group natural polysaccharide antigens. It also occurs partially in response to polysaccharides in the intestinal flora. Antibodies against blood groups A and B may not develop in the first 1-2 years of life, especially within the first 6 months. Isohemagglutin is not found in patients with the blood group AB. Again, under the age of 1-2, the response of isohemagglutinin cannot be trusted. [2] In general, ≥1:4 titer is adequate in small children, while in adolescents and adults, ≥1:10 is considered adequate. [20] These tests are more useful in differentiating transient hypogammaglobulinemia from permanent Bruton or CVID (common variable immune deficiency) (Table 2a) . [2] [3] [4] [5] [6] [7] [8] [9] Specific antibody responses to protein/ polysaccharide vaccines
First of all, patients should be examined for the presence of a protective titer. If there is no protective titer, one dose of vaccine is given, and 2-4 weeks later, a four-fold increase observed in protein vaccines and a two-fold increase in polysaccharide vaccines are considered to be an adequate response. Normally, these titers are expected to continue for more than 6 months. There is no response to more than 50% of the serotypes of the pneumococcal vac- cine in children with a specific antibody deficiency, above the protective titer of 1.3 ug/ml in children aged <6 years. In children >6 years of age, there is no response to more than 70% of serotypes of the vaccine. Some details on how to evaluate these vaccine responses are shown in Table 2b .
Titers of other routine/known vaccines (tetanus, diphtheria, Hib, meningococci, polio, MMR) can also be sought for. Since the patients receiving IVIG will have antibodies against other known antigens, Bacteriophage (Phi) φ X174 called neoantigen developed against it will be investigated. Also known past diseases (EBV, CMV, Varicella-Zoster, etc.) are evaluated during the post-infectious period, and antibody titers against them are examined. Specific antibody tests, such as isohemagglutinin, are also used to distinguish transient hypogammaglobulinemia from permanent hypogammaglobulinemias (Bruton or CVID [diffuse variable immunodeficiency, etc.]). [2] [3] [4] [5] [6] [7] [8] [9] As a result, antibody deficiency (humoral deficiency) and its type are tried to be diagnosed based on the presence of the immunoglobulin isotype (group), IgG subgroup, vaccine response, and B cells in the blood (Table 3) .
2) Assessment of cellular (and combined) immunodeficiency
As a screening test, it is necessary to show whether lymphopenia is primarily related to an HIV infection (by measuring anti-HIV and HIV viral load). Lymphocyte immunophenotyping and skin tests for delayed-type hypersensitivity are included in these basic screening tests. Among advanced stage tests T-cell proliferation (mitogen, recall), T-cell cytokines, flow cytometric intracellular and cell surface detection (WASP, SAP intracellular molecules and CD40L: CD154, IL-2Rγ (gamma) chain: CD132, IL-7Rα: CD127, MHC-I/II surface expressions, etc.), enzyme studies (ADA, PNP, etc.), FISH, T-cell receptor excision circles (TREC), T-cell receptor repertoire, and mutation analysis are available (Table 4) . , it should be considered that it may be due to the Omenn syndrome maternal engrafmant (the cells passing to the child through the mother) or atypical (leaky) AKI. [8, 21] If a low CD3 + -T lymphocyte count (<300/mm 3 ) is associated with severe neutropenia (<200/mm 3 ), impaired lymphatic proliferation with phenytohemagglutinin (PHA), arrest in myeloid series in the bone marrow, and deafness, the diagnosis of reticular dysgenesis due to the adenylate kinase 2 mutation is considered. [22] Evaluation of lymphocyte function (proliferation)
It is possible to evaluate the lymphocyte function using different stimuli (mitogen, antigen, and recall antigen). PHA, concanavalin A (ConA), anti-CD3, or pokeweed mitogen are used as mitogens. As an antigen, tetanus and candida are used; as recall antigens, tetanus, monilial, and mumps, which are pathogens that can be easily encountered in each individual's life, are used. Fluorescent dyes such as radioactive nucleoside 3H-thymidine, carboxy fluorescein succinimidyl ester, and cell violet are used to measure immune cell proliferation. [2] T-cell (TCR-Vβ chain) repertoire is normally stable and polyclonal in T lymphocytes. In the presence of clonality or oligoclonality, conditions such as malignancy, infections (HIV, EBV, CMV, etc.), aging, autoimmunity, Omenn syndrome, CID, and atypical DiGeorge syndrome (DGS) should be considered. [6] T-cell receptor (TCR-Vβ chain) repertoire can be investigated using flow cytometry and PCR (spectratyping). [23] T-cell receptor excision circles (TREC) screening test
These are the residual extracellular DNA residues during the development of T cells and the formation of the receptor. As T cells proliferate, these DNA residues become diluted, and their concentration in the cytoplasm may be less difficult to detect. These cells are labeled with CD4 + -CD45RA + -CD31 + T cells with monoclonal antibodies in flow cytometry. This test was originally developed for neonatal screening and early detection of SCIDs. [6, 8] Although it cannot detect a type of SCID such as ADA deficiency, it can identify T-cell defects leading to severe lymphopenia with some other CIDs (ataxia-telangiectasia, CHARGE syndrome, DGS, trisomy 21, leaky [variant] SCID types, etc.). [24, 25] Again, it should be known that sometimes in premature cases, false positive results should be obtained. It is also used in the evaluation of immunoreconstitution after hematopoietic stem cell transplantation because it also indicates the presence of naive T cells. [26] 3) Evaluation of phagocytic system deficiencies If the patient presents with complaints such as delayed detachment of the umbilical cord (>1 months), inflammation without pus, gingivitis and impaired wound healing, we should consider and search for the phagocytic system disorders and examine them. [2] [3] [4] [5] [6] [7] [8] [9] We can recognize systemic diseases by measuring the phagocyte cell surface expressions and intracellular oxidative burst.
Measuring surface expressions of phagocytic cells in flow cytometry. A leukocyte adhesion defect (LAD) can be identified by this method. In the flow cytometric examination of peripheral blood, Type 1 LAD disease is diagnosed by detecting the absence of these expressions in the patient cells by comparing the staining with CD18/CD11a-b-c monoclonal markers used after the neutrophil-phagocyte cell uptake. [4, 8] Type 2 LAD is diagnosed if the CD15 expression is not found in patient cells. [8] Nitroblue tetrazolium reduction test Nitroblue tetrazolium (NBT) solution is a colorless or pale yellow (when oxidized) chemical substance. Formazan is formed when oxidized by oxidase in the neutrophils (phagocytes) (with the production of superoxides by oxidative burst), and the cell cytoplasm becomes dark blue. Microscopic examination normally shows neutrophils with blue-stained cytoplasm. It is possible to make assessments using (evoked) or not using stimuli (nonevoked). The method is semiquantitative and subjective. X-chronic granulomatous disease may overlook carrier and hypomorphic mutations. Stimulated (evoked) control cells demonstrate a ≥90% positivity (blue staining in cells), and a ≤10-90% positivity is observed in the phagocytic cells of the disease carriers. If there is a ≤70% positivity in evoked phagocytic cells, disease or carriership should be considered. As oxidative explosion disorders, chronic granulomatous disease (CGD), complete glucose-6-phosphate dehydrogenase, and myeloperoxidase (MPO) deficiency should be considered. [27, 28] It appears that, nowadays, this test is replaced by a below-mentioned dihydro-rhodamine (DHR) test.
Dihydro-rhodamine 1,2,3 or 2'7, dichlorofluorosein diacetate tests
These can be performed in flow cytometry, which is developed to measure oxidation (oxidative burst) in the cell, and they are now becoming more popular and accepted as the alternative tests to gold standard NBT test. In their evaluation, the mean fluorescence index on the histogram after the oxidation increases, and the right shift is observed. [29] This test used instead of NBT seems to be superior to NBT in detecting carriers and other types of CGD (autosomal or X-linked). [30] Determination of myeloperoxidase deficiency This disease, which is usually asymptomatic, autosomal recessive, and has a frequency of 1:4,000 is also known as the most common phagocyte system defect. In the myeloperoxidase deficiency contained in the azurophilic granules, some cells are found to be unstained with routine dyes (benzidine-containing hydrogen peroxide/ethanol solution), and the difference between the counts on the hemogram. [31] Reactive increases the toxicity of oxygen radicals. There is an increase in Candida and Aspergillus infections and diabetes mellitus. In addition, MPO deficiency in the flow cytometry to gate phagocytic cells (gate) is done by monoclonal marking in the cell containing myeloperoxidase. [32, 33] 
4) Evaluation of immune dysregulation disorders
Immunodeficiency diseases should be considered if there are findings suggestive of specific lymphadenopathy, hepatosplenomegaly, or autoimmune diseases. In addition to other laboratory and clinical findings, flow cytometric investigations are used in the foreground and most frequently. For example, autoimmune lymphoproliferative syndrome (ALPS) from immune dysregulation diseases is one of the first that comes to our mind. Elevated levels of serum B12 (>1500 ng/l), plasma FasL (>200 pg/ml), IL-10 (20 pg/ml), and IL-18 (500 pg/ml) are also helpful in the diagnosis of ALPS. [27, 34, 35] Detection of the most common immune dysregulation disorders in flow cytometry
In the flow cytometry, the diagnosis of apoptosis in double negative T cells (CD3 + -CD4-CD8-TCR αβ+ ) (>2.5%) is helpful in the diagnosis. [34, 35] Decreased LAMP (CD107a) expression is seen in flow cytometry in diseases with immunodeficiency disorders (familial hemophagocytic lymphohistiocytosis). [36] In addition, X-linked lymphoproliferative syndromes Type 1 and Type 2 (XLP1 and XLP2) can also be identified by flow cytometric examination based on the expression of SAP and XIAP. [38] 
5) Complement deficits assessment
The prevalence of complement deficiencies (complementopathy) is known to be 0.03% in the community. [39] We should consider the lack of complement in the clinic when we encounter disease tables such as Neisseria meningitis, SLE, (typical or atypical) hemolytic uremic syndrome, and paroxysmal nocturnal hemoglobinuria (Table 5 ).
How should we evaluate the complement system? CH50 and AH (AP) 50 tests are used to evaluate classical and alternative complement pathways. The CH50 test is as low as zero, and when AH (AP) 50 is normal, it suggests a lack of one of the classic complement pathway elements C1-C9. Only in C9 deficiency, the CH50 will be reduced by no more than 50%. If the CH50 level is higher than zero, consumption-related deficiency should be considered in diseases such as SLE. When AH (AP) 50 is zero and CH50 is normal, the Factor B/D deficiency of the alternative pathway should be considered. The values of AH (AP) 50, which are higher than zero, are seen in Factor H/I and properdin deficiency (Table 5 ). 
Determination of complement deficiencies in flow cytometry
Recently, Özen et al. [40] described the expression deficiency of one of the complement regulator proteins (CD55). Because of the initials of the symptoms in English, CHAPLE is also known as the CD55 deficiency, angiopathic thrombosis and protein-losing enteropathy syndrome with complement hyperactivity. Also, paroxysmal nocturnal hemoglobinuria with hemolysis, thrombosis, and polyneuropathy due to lack of expression of the membrane attack complex inhibitor (CD59) has been described.
6) Natural/structural immune disorders
These disorders of the immune system are susceptible to tuberculosis and some viral (human herpes and papilloma) infections. The susceptibility to tuberculosis infections occurs with the lack of expression of certain cytokines and receptors (IFN-γR1, IL-12, and IL-23Rβ1). [43] Some viral (human herpes and papilloma virus) susceptibility to infections may occur due to CD16, TLR3 pathway deficiencies. [8, 44, 45] Again, susceptibility to invasive bacterial infections as an indicator of IRAQ4 deficiency may be seen with granulocytes and CD62L shedding disorder. The susceptibility to chronic mucocutaneous candidiasis goes with a lack of the IL-17F/RA/RC expression. [10, 46] Flow cytometry is able to measure these cytokines and their receptors, as well as the surface protein expression such as CD16, TLR3, and CD62L.
In summary, the most commonly seen and considered four (humoral, cellular/combined, phagostic, and complement disorders) disorders from this review are summarized in Table 6 as a large PID group.
CONCLUSION
Primary immunodeficiencies are very heterogeneous and more common than we think. The recognition SCID cases is a pediatric emergency. The knowledge of simple diagnostic/screening tests by each physician will allow an easy and quick evaluation. Genetic and advanced tests, which can only be performed in certain centers, have an important role in the diagnosis of a large part of PIDD. 
Evaluation of complement system (complementopathy)
Measurement of CH50 (total hemolytic complement activity) Analysis of levels or functions of specific complement components Measurement of AH50 (alternative hemolytic activity pathway) Investigation of the lectin pathway function Early guidance and interpretation of these tests will increase the chance of early diagnosis and treatment in the centers that will perform these simple and advancedstage tests.
